Neurotrophic Keratopathy After Slow Coagulation Transscleral Cyclophotocoagulation.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
03
03
2023
accepted:
10
05
2023
medline:
8
11
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
Decreased corneal sensation and subsequent neurotrophic keratopathy (NK) is an uncommon complication after transscleral cyclophotocoagulation (TSCPC). Post-TSCPC NK has been rarely reported in the literature, predominantly after traditional, "pop technique" continuous-wave TSCPC or micropulse CPC. The authors report the first case series of NK after slow-coagulation TSCPC (SC-TSCPC). This was a respective chart review of patients who developed NK after SC-TSCPC. The collected data included demographic data, type of glaucoma, risk factors for corneal anesthesia in addition to the number of laser spots, and the extent of the treated area. Four eyes experienced NK after SC-TSCPC. The median time for the development of NK was 4 weeks. At the final visit, 2 patients had a resolution of NK, 1 had a persistent corneal ulcer, and 1 had worsening NK and corneal perforation. NK is a rare but a vision-threatening complication that can develop after SC-TSCPC in patients with risk factors for decreased corneal sensation. Early diagnosis and proper management are crucial to reducing the risk of vision loss and improving the prognosis of these cases.
Identifiants
pubmed: 37535806
doi: 10.1097/ICO.0000000000003325
pii: 00003226-202312000-00018
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1582-1585Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Dua HS, Said DG, Messmer EM, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107–131.
Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571–579.
Shah P, Bhakta A, Vanner EA, et al. Safety and efficacy of diode laser transscleral cyclophotocoagulation in eyes with good visual acuity. J Glaucoma. 2018;27:874–879.
Duerr ER, Sayed MS, Moster S, et al. Transscleral diode laser cyclophotocoagulation: a comparison of slow coagulation and standard coagulation techniques. Ophthalmol Glaucoma. 2018;1:115–122.
Khodeiry MM, Liu X, Lee RK. Clinical outcomes of slow-coagulation continuous-wave transscleral cyclophotocoagulation laser for treatment of glaucoma. Curr Opin Ophthalmol. 2022;33:237–242.
Fernández-Vega González Á, Barraquer Compte RI, Cárcamo Martínez AL, et al. Neurotrophic keratitis after transscleral diode laser cyclophotocoagulation. Arch de la Soc Esp de Oftalmol (English Edition). 2016;91:320–326.
Johnson SM. Neurotrophic corneal defects after diode laser cycloablation. Am J Ophthalmol. 1998;126:725–727.
Perez CI, Han Y, Rose-Nussbaumer J, et al. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmol Case Rep. 2019;15:100469.
Sesma G, Ahmad K, AlBakri A, et al. Incidence and outcomes of microbial keratitis after cyclophotocoagulation to treat childhood refractory glaucoma. J Am Assoc Pediatr Ophthalmol Strabismus. 2022;26:124.e1–124.e5.
Jabbour S, Ashton C, Balal S, et al. The management of neurotrophic keratitis. Curr Opin Ophthalmol. 2021;32:362–368.
Elhusseiny AM, Traish AS, Saeed HN, et al. Topical cenegermin 0.002% for pediatric neurotrophic keratopathy. Eur J Ophthalmol. 2022;32:3420–3424.